| Market Cap | ₹310Cr |
| ROE | 7.77% |
| P/E Ratio(TTM) | 16.55 |
| EPS(TTM) | 0.77 |
| P/B Ratio | 1.45 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.14 |
| Book Value | 8.79 |
| Debt to Equity | 0.41 |
| Face Value | 1 |
| Parent Organisation | Gennex Laboratories Limited |
| Managing Director | Arihant Baid |
| Founded | 1990 |
| BSE Symbol | 531739 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.62 | ||
| Neuland Laboratories | NA (0.00%) | 79.94 | ||
| Jubilant Pharmova | NA (0.00%) | 36.07 | ||
| Acutaas Chemicals | NA (0.00%) | 59.91 |